Flavahan N A, Hales M A, Aleskowitch T D, Gaine S P, Vanhoutte P M
Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
J Cardiovasc Pharmacol. 1998 Aug;32(2):308-16. doi: 10.1097/00005344-199808000-00020.
The aim of this study was to characterize the alpha-adrenoceptors of the canine pulmonary artery. Arterial rings from lower lung lobes were suspended for isometric-tension recording in the presence of cocaine (5 x 10(-6) M), hydrocortisone (3 x 10(-5) M), propranolol (5 x 10(-6) M), and rauwolscine (10(-7) M) to inhibit neuronal uptake, extraneuronal uptake, and beta- and alpha2-adrenoceptors, respectively. Prazosin was more potent against contractions evoked by phenylephrine (pA2 of 9.7) compared with methoxamine (pA2 of 8.4). SZL49 (10(-8) and 3 x 10(-8) M), an irreversible alpha1-adrenergic antagonist, inhibited responses to phenylephrine but not methoxamine. With norepinephrine, low concentrations of prazosin (3 x 10(-10) M and 10(-9) M) caused inhibition of the concentration-response curve; a higher concentration (3 x 10(-9) M) failed to produced further inhibition, whereas increasing the concentration of the antagonist (to 10(-8) and 3 x 10(-8) M) caused further rightward shifts in the concentration-response curve. The Arunlakshana and Schild plot revealed two components corresponding to pA2 values of 9.8 and 8.4. After SZL49 (3 x 10(-8) M), the Arunlakshana and Schild plot for the interaction between norepinephrine and prazosin was linear and generated a pA2 of 8.3. Contractions evoked by phenylephrine were inhibited by the alpha1B/alpha1D-adrenoceptor antagonist, chloroethylclonidine (10(-5) M), or by the alpha1B-antagonist, risperidone (pA2 value of 8.5), but were relatively resistant to inhibition by the selective alpha1D-antagonist, BMY7378 (-log K(B) of 6.1). The results suggest that two alpha1-adrenoceptor subtypes mediate contraction of the canine pulmonary artery. One subtype has high affinity for prazosin (alpha1H, likely to be alpha1B), is activated by phenylephrine, and is inhibited by SZL49. The other subtype has lower affinity for prazosin (alpha1L), is stimulated by methoxamine, and is relatively resistant to SZL49. The physiologic agonist, norepinephrine, causes contraction by activating both subtypes.
本研究的目的是对犬肺动脉的α-肾上腺素能受体进行特征描述。取右下肺叶的动脉环,在存在可卡因(5×10⁻⁶ M)、氢化可的松(3×10⁻⁵ M)、普萘洛尔(5×10⁻⁶ M)和育亨宾(10⁻⁷ M)的情况下进行等长张力记录,以分别抑制神经元摄取、非神经元摄取以及β-和α₂-肾上腺素能受体。与甲氧明(pA₂为8.4)相比,哌唑嗪对去氧肾上腺素诱发的收缩作用更强(pA₂为9.7)。不可逆的α₁-肾上腺素能拮抗剂SZL49(10⁻⁸和3×10⁻⁸ M)抑制了对去氧肾上腺素的反应,但对甲氧明无抑制作用。对于去甲肾上腺素,低浓度的哌唑嗪(3×10⁻¹⁰ M和10⁻⁹ M)导致浓度-反应曲线受到抑制;较高浓度(3×10⁻⁹ M)未能产生进一步抑制,而增加拮抗剂浓度(至10⁻⁸和3×10⁻⁸ M)导致浓度-反应曲线进一步右移。阿伦拉克沙纳和希尔德作图显示出两个成分,其pA₂值分别为9.8和8.4。在给予SZL49(3×10⁻⁸ M)后,去甲肾上腺素与哌唑嗪相互作用的阿伦拉克沙纳和希尔德作图呈线性,产生的pA₂为8.3。去氧肾上腺素诱发的收缩受到α₁B/α₁D-肾上腺素能受体拮抗剂氯乙可乐定(10⁻⁵ M)或α₁B-拮抗剂利培酮(pA₂值为8.5)的抑制,但对选择性α₁D-拮抗剂BMY7378的抑制作用相对不敏感(-log K(B)为6.1)。结果表明,两种α₁-肾上腺素能受体亚型介导犬肺动脉的收缩。一种亚型对哌唑嗪具有高亲和力(α₁H,可能是α₁B),被去氧肾上腺素激活,并被SZL49抑制。另一种亚型对哌唑嗪的亲和力较低(α₁L),被甲氧明刺激,且对SZL49相对不敏感。生理性激动剂去甲肾上腺素通过激活这两种亚型引起收缩。